百度(09888.HK)與歐加隆達成戰略合作
百度(09888.HK)旗下百度健康與醫療健康公司歐加隆達成戰略合作,雙方將探索數字化、精準化的疾病健康教育模式,打造優質權威的健康科普內容,同時構建健康教育專區,連結用戶健康需求、高質量科普內容與互聯網健康服務。
百度集團資深副總裁何明科表示,在後疫情時代科技在醫療健康領域發揮的作用逐漸顯現,集團希望結合自身能力、優勢,賦能醫療健康產業,用科技讓優質醫療健康服務實現普惠,此次與歐加隆合作探索疾病教育生態,期望可更好地滿足用戶在互聯網端求醫問診和健康自我管理的需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.